Australia markets closed

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
46.05+0.17 (+0.37%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 59.16B
Enterprise value 53.32B
Trailing P/E 19.13
Forward P/E 16.47
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.29
Price/book (mrq)2.91
Enterprise value/revenue 2.08
Enterprise value/EBITDA 12.91

Trading information

Stock price history

Beta (5Y monthly) 0.41
52-week change 3-5.29%
S&P500 52-week change 323.76%
52-week high 350.65
52-week low 331.17
50-day moving average 346.47
200-day moving average 340.51

Share statistics

Avg vol (3-month) 38.01M
Avg vol (10-day) 38.26M
Shares outstanding 51.28B
Implied shares outstanding 61.28B
Float 8230.88M
% held by insiders 163.10%
% held by institutions 114.39%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.5
Forward annual dividend yield 43.26%
Trailing annual dividend rate 31.15
Trailing annual dividend yield 32.52%
5-year average dividend yield 41.62
Payout ratio 431.95%
Dividend date 3N/A
Ex-dividend date 414 June 2024
Last split factor 21.3:1
Last split date 314 June 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 11.94%
Operating margin (ttm)24.57%

Management effectiveness

Return on assets (ttm)5.93%
Return on equity (ttm)13.90%

Income statement

Revenue (ttm)25.68B
Revenue per share (ttm)20.14
Quarterly revenue growth (yoy)14.80%
Gross profit (ttm)N/A
EBITDA 4.49B
Net income avi to common (ttm)3.07B
Diluted EPS (ttm)2.41
Quarterly earnings growth (yoy)18.50%

Balance sheet

Total cash (mrq)8.83B
Total cash per share (mrq)6.87
Total debt (mrq)2.99B
Total debt/equity (mrq)11.63%
Current ratio (mrq)1.88
Book value per share (mrq)15.84

Cash flow statement

Operating cash flow (ttm)4.68B
Levered free cash flow (ttm)2.64B